Aktis Oncology(AKTS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

AKTS Aktis Oncology

交易中 06-08 11:43:34 EDT

19.25

+0.38

+2.01%

最高19.72	最低18.88	成交量5.29万
今开19.00	昨收18.87	日振幅4.43%
总市值10.64亿	流通市值3.40亿	总股本5,528万
成交额101.41万	换手率0.30%	流通股本1,765万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"AKTS","market":"US","secType":"STK","nameCN":"Aktis Oncology","latestPrice":19.25,"timestamp":1780933411520,"preClose":18.87,"halted":0,"volume":52861,"delay":0,"changeRate":0.020137784843667142,"floatShares":17650000,"shares":55276000,"eps":-1.213,"marketStatus":"交易中","change":0.38,"latestTime":"06-08 11:43:34 EDT","open":19,"high":19.715,"low":18.88,"amount":1014064.332461,"amplitude":0.04425,"askPrice":19.32,"askSize":4,"bidPrice":19.18,"bidSize":400,"shortable":3,"etf":0,"ttmEps":-1.213,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1780948800000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1767934800000,"exchange":"NASDAQ","adjPreClose":18.87,"postHourTrading":{"tag":"盘后","latestPrice":18.87,"preClose":18.87,"latestTime":"16:57 EDT","volume":1648,"amount":31100.08,"timestamp":1780693044406,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.794301,"impliedVol":1.5345,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/AKTS/tweets","defaultTab":"tweets","newsList":[{"id":"1118503352","title":"Aktis Oncology公布Aky-2519首次人体临床影像与剂量学数据，显示在表达B7-H3的肿瘤患者中实现强劲肿瘤摄取且正常组织暴露有限","url":"https://stock-news.laohu8.com/highlight/detail?id=1118503352","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1118503352?lang=zh_cn&edition=full","pubTime":"2026-05-22 05:22","pubTimestamp":1779398536,"startTime":"0","endTime":"0","summary":"Aktis Oncology公布了其靶向放射性药物候选产品Aky-2519的首次人体临床影像与剂量学数据。这些早期数据显示，在表达B7-H3的肿瘤患者中，Aky-2519表现出强劲且特异的肿瘤摄取，同时对正常组织的辐射暴露保持在有限水平。公布的临床数据表明，Aky-2519能够有效地在肿瘤部位积聚，从而实现针对肿瘤的高剂量辐射，同时最大程度地减少对周围健康组织的潜在损伤。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AKTS","BK4148"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168992125","title":"Aktis Oncology启动AKY-2519治疗转移性去势抵抗性前列腺癌的1B期临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1168992125","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1168992125?lang=zh_cn&edition=full","pubTime":"2026-05-05 04:06","pubTimestamp":1777925205,"startTime":"0","endTime":"0","summary":"Aktis Oncology公司正式启动其创新药物AKY-2519的1B期临床试验。该药物是一种靶向B7-H3的微型蛋白放射性偶联物，主要针对转移性去势抵抗性前列腺癌（MCRPC）患者群体。\n这项临床研究的开展标志着公司在肿瘤治疗领域取得重要进展。AKY-2519通过其独特的微型蛋白设计，能够精准靶向肿瘤细胞表面过度表达的B7-H3抗原，并携带放射性同位素实现对癌细胞的精准杀伤。\n对于罹患转移性去势抵抗性前列腺癌的患者而言，这一新疗法的研发为他们带来了新的治疗希望。随着临床试验的推进，医学界期待能够获得更多关于该药物安全性和有效性的关键数据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AKTS","BK4148"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196039937","title":"Aktis Oncology宣布AKY-2519新药临床试验申请获FDA批准，并公布业务进展及2025财年财务业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=1196039937","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1196039937?lang=zh_cn&edition=full","pubTime":"2026-03-31 04:02","pubTimestamp":1774900933,"startTime":"0","endTime":"0","summary":"生物技术公司Aktis Oncology宣布，其核心候选药物AKY-2519的新药临床试验（IND）申请已获得美国食品药品监督管理局（FDA）的正式批准。此次监管绿灯意味着公司可启动针对实体瘤的临床一期试验，标志着其放射性药物研发平台迈入关键验证阶段。\n与此同时，Aktis Oncology同步披露了2025财年全年财务数据及业务进展。财报显示，公司通过战略融资活动进一步巩固了资金储备，为后续临床开发提供持续支持。管理层在业务更新中强调，将加速推进管线内多项靶向放射疗法的临床前研究，并拓展与制药企业的合作生态。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4148","AKTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155480717","title":"Aktis Oncology旗下Nectin-4微型蛋白放射性偶联物AKY-1189获美国FDA快速通道资格认定","url":"https://stock-news.laohu8.com/highlight/detail?id=1155480717","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155480717?lang=zh_cn&edition=full","pubTime":"2026-02-24 21:01","pubTimestamp":1771938074,"startTime":"0","endTime":"0","summary":"生物技术公司Aktis Oncology宣布，其研发的靶向Nectin-4的微型蛋白放射性偶联物AKY-1189，已获得美国食品药品监督管理局（FDA）授予的快速通道资格。这一认定将加速该候选药物的临床开发及审评进程，为晚期实体瘤患者提供新的治疗希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4148","AKTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608899870","title":"华尔街顶级分析师最新评级：奥多比遭下调，帕兰提尔获上调","url":"https://stock-news.laohu8.com/highlight/detail?id=2608899870","media":"环球市场播报","labels":["rating"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608899870?lang=zh_cn&edition=full","pubTime":"2026-02-03 22:46","pubTimestamp":1770129960,"startTime":"0","endTime":"0","summary":"华尔街最受关注、对市场影响显著的分析师评级报告现已汇总呈现。以下为 The Fly 整理的、投资者需重点关注的今日最新评级调整信息。该行称，估值因素是此次评级下调的核心原因，目前埃克森美孚的市盈率处于五年高位。该行对阿克蒂斯肿瘤的发展前景持积极态度：公司正致力于拓展放射性药物的治疗靶点领域，其管线项目有望成为首款同类创新药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-02-03/doc-inhkqfvc7106899.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"rating","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0719512351.SGD","LU0289739343.SGD","LU0109392836.USD","LU0109391861.USD","CTRA","LU0057025933.USD","LU0342679015.USD","LU0792757196.USD","LU0061474960.USD","LU0557290698.USD","QTWO","IE00BQXX3C00.GBP","IE00BYQQ9H92.USD","LU2360032135.SGD","IE00BQXX3D17.EUR","ADBE","PLTR","BK4588","BK4592","LU1674673428.USD","SGXZ99366536.SGD","LU1720051017.SGD","LU1119994496.HKD","AKTS","LU0289961442.SGD","LU0234572021.USD","LU2458330169.SGD","LU0868494708.USD","LU2089283258.USD","LU2210149790.SGD","BK4528","LU1803068979.SGD","BK4567","BK4581","LU1778281490.HKD","LU0965509283.SGD","LU0158827948.USD","LU1712237335.SGD","LU0157215616.USD","LU1261432733.SGD","AFRM","IE00B5TLWC47.USD","LU0345774391.USD","LU1674673691.USD","IE0009356076.USD","DIS","LU1235294995.USD","LU0942090050.USD","LU0106261372.USD","LU2089284900.SGD","LU0320765059.SGD","SG9999001424.SGD","LU2125154778.USD","LU1633808545.USD","ELV","LU0708995401.HKD","LU1046421795.USD","IE00BQXX3F31.USD","BK4527","LU0234570918.USD","SGXZ81514606.USD","LU0861579265.USD","BK4566","SG9999000418.SGD","LU2023251221.USD","LU2317271919.USD","LU0511384066.AUD","JBLU","BK4534","BK4533","LU0672654240.SGD","LU0889565833.HKD","LU0348723411.USD","BK4543","BK4554","LU0082616367.USD","FIGR","IE00B19Z9505.USD","LU0006306889.USD","LU1623119135.USD","LU0081259029.USD","LU0889566641.SGD","LU2095319765.USD","LU0957791311.USD","LU1691799644.USD","LU1815333072.USD","MA","LU2237438978.USD","LU1267930813.SGD","LU2210150020.SGD","IE00BFXG0V08.USD","LU0170899867.USD","LU1720051108.HKD","LU2236285917.USD","LU1267930730.SGD","SGXZ51526630.SGD","LU1823568750.SGD","SGMT","STAA","LU0868494617.USD","TASK","BK4023","LU2458330243.SGD","LU1084165304.USD","LU0965509101.SGD","LU1548497426.USD","LU0472753341.HKD","LU0198837287.USD","XOM","LU1366333091.USD","LU0069063385.USD","LU2357305700.SGD","LU0965509010.AUD","LU0314104364.USD","LU2125154935.USD","BK4585","LU0345774631.USD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2604181779","title":"生物技术公司Aktis纳斯达克上市：市值10亿美元 礼来公司加持","url":"https://stock-news.laohu8.com/highlight/detail?id=2604181779","media":"雷递网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604181779?lang=zh_cn&edition=full","pubTime":"2026-01-19 17:14","pubTimestamp":1768814089,"startTime":"0","endTime":"0","summary":"临床阶段生物技术公司Aktis Oncology（股票代码：“AKTS”）日前在美国纳斯达克上市。截至上周五收盘，Aktis Oncology股价为19.75美元，市值为10.37亿美元。","market":"hk","thumbnail":"https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260119/6390443968152136573197612.jpeg","type":0,"news_type":0,"thumbnails":["https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260119/6390443968152136573197612.jpeg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.leinews.com/n32415/detail.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"leinews_highlight","symbols":["LU0889565916.HKD","LU1551013425.SGD","LU1868836914.USD","SGXZ57979304.SGD","IE00BJJMRY28.SGD","LU1917777945.USD","LU2264538146.SGD","LU2168563687.JPY","LU2456880835.USD","SGXZ99366536.SGD","LU0203201768.USD","LU0289739699.SGD","LU1366192091.USD","LU1069344957.HKD","LU2237443382.USD","IE00BFSS8Q28.SGD","LU2108987350.USD","QID","LU2357305700.SGD","LU2750360997.AUD","QQQY","LU0823416689.USD","LU2602419157.SGD","PSQ","IE00B775H168.HKD","LU0353189680.USD","BK4007","LU0882574139.USD","LU2237443622.USD","LU2746668461.USD","USJW.SI","LU2168564495.EUR","LU0096364046.USD","LU1551013342.USD","LU1983299246.USD","LU1035775433.USD","LU0094547139.USD","IE00B1BXHZ80.USD","LU0109391861.USD","SG9999015945.SGD","LU2471134879.HKD","LU0058720904.USD","QQQM","LU1023059063.AUD","USAW.SI","BK4516","LU0471298777.SGD","LU0122379950.USD","AKTS","LU0456855351.SGD","BK4533","IE00BJJMRZ35.SGD","LU0823434740.USD","LU1057294990.SGD","LU1280957306.USD","LU2552382058.USD","LU0672654240.SGD","LU1061106388.HKD","LU2087625088.SGD","IE0009355771.USD","LU2112291526.USD","LU2211815571.USD","LU1868836591.USD","LU2237438978.USD","LU0203202063.USD","LU0106261372.USD","LU0079474960.USD","LU1712237335.SGD","LU0114720955.EUR","LU1814569148.SGD","IE00BJT1NW94.SGD","SG9999001176.USD","LU2491050071.SGD","IE00BK4W5L77.USD","LU2265009873.SGD","LU2552382132.HKD","QYLG","LU0943347566.SGD","IE00BFTCPJ56.SGD","SG9999014898.SGD","LU0820561909.HKD","BK4585","SG9999015952.SGD","QLD","SGXZ51526630.SGD","LU0323591593.USD","LU1868836757.USD","SQQQ","LU2360106947.USD","SGXZ81514606.USD","IE00B2B36J28.USD","LU0198837287.USD","LU1127390331.HKD","LU2168564222.USD","LU2237443978.SGD","LU1232071149.USD","NVIW.SI","LU0316494557.USD","LU0354030438.USD","LU1720051108.HKD","LU0432979614.USD","LU2471134952.CNY","SGXZ31699556.SGD","TQQQ","LU0882574055.USD","LU2471134523.USD","BK4581","SG9999014906.USD","LU2023250504.SGD","LU0006306889.USD","LU2461242641.AUD","LU1548497426.USD","LU2168564065.EUR","LU0708995401.HKD","TSYW.SI","QQQE","GB00BDT5M118.USD","QYLD","MNQmain","LU0266013472.USD","LU2417539215.USD","LU2491050154.USD","LU2236285917.USD","LU2750360641.GBP","LU2468319806.SGD","SG9999001176.SGD","IE0004445015.USD","LU0061475181.USD","LU2237443895.HKD","IE0004445239.USD","LU2552382215.SGD","LU1267930730.SGD","LU0256863902.USD","LU0689472784.USD","BK4599","LU2361045086.USD","SG9999015986.USD","LU0466842654.USD","LU2471134796.USD","LU1323610961.USD","LU0417517546.SGD","LU1064131342.USD","LU1804176565.USD","LU0385154629.USD","LU0471298694.HKD","NQmain","LU2361044865.SGD","LU0097036916.USD","BK4534","IE00B1XK9C88.USD","LU0787776722.HKD","LU1291159041.SGD","LU2462157665.USD","LU1868837136.USD","IE00BWXC8680.SGD","LU2168564149.EUR","LU2237443465.HKD","LU1623119135.USD","LU1868837300.USD","IE0005OL40V9.USD","IE00BJLML261.HKD","LU0234572021.USD","LU0683600562.USD","LU1720051017.SGD","SG9999018857.SGD","LU2491049909.HKD","QQQJ","LU0786609619.USD","LU2089984988.USD","LLY","LU0320765059.SGD","BK4588","LU2361044949.HKD","IE00B4R5TH58.HKD","IE00BKPKM429.USD","LU0109394709.USD","IE00BN29S564.USD","IE0002141913.USD","LU2746668974.SGD","LU0256863811.USD","IE00B7KXQ091.USD","IE00BK4W5M84.HKD","LU0320765992.SGD","SG9999015978.USD","SG9999014880.SGD","GPIQ","LU0353189763.USD","IE00BKDWB100.SGD","LU1093756168.USD","LU1989771016.USD","SG9999013999.USD","LU0823434583.USD","LU1093756325.SGD","IE00BFSS7M15.SGD","SG9999014914.USD","LU1988902786.USD","IE00B4JS1V06.HKD","LU2324357040.USD","LU2106854487.HKD","SG9999017495.SGD","LU0640476718.USD","LU2063271972.USD","LU0820561818.USD","LU0238689110.USD","BK1147","LU1974910355.USD","IE00BJJMRX11.SGD","LU0225283273.USD","LU2237443549.SGD","LU0354030511.USD","SG9999018865.SGD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1103399184","title":"异动解读 | Aktis Oncology盘中大涨50%，IPO定价及礼来认购提振股价","url":"https://stock-news.laohu8.com/highlight/detail?id=1103399184","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1103399184?lang=zh_cn&edition=full","pubTime":"2026-01-10 00:14","pubTimestamp":1767975278,"startTime":"0","endTime":"0","summary":"Aktis Oncology今日盘中大涨50%，引起了市场的广泛关注。消息面上，该公司今晚将在纳斯达克上市，通过发行1770万股股票，每股定价18美元，募集了3.18亿美元。礼来已表示将认购价值1亿美元的股票，这一重大投资显著提升了市场对Aktis Oncology的信心。Aktis Oncology是一家临床阶段的肿瘤学公司，专注于开发针对常见实体瘤的α粒子放射性药物。其研发管线包括针对Nectin-4表达癌症的Ac-AKY-1189和针对B7-H3表达肿瘤的Ac-AKY-2519，预计将在未来几年取得重要进展。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["AKTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2602325008","title":"今晚登陆纳斯达克！Aktis Oncology IPO定价每股18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2602325008","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602325008?lang=zh_cn&edition=full","pubTime":"2026-01-09 17:52","pubTimestamp":1767952372,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，专注于开发靶向放射性药物以治疗实体瘤的临床一期生物技术公司Aktis Oncology今晚将在纳斯达克上市，通过发行1770万股股票，每股定价18美元，募集了3.18亿美元。合作伙伴礼来已表示将认购价值1亿美元的股票。定价完成后，Aktis的完全稀释市值达到10亿美元。Aktis Oncology是一家临床阶段的肿瘤学公司，致力于开发针对常见实体瘤的α粒子放射性药物。摩根大通、美银证券、里林克合伙公司和TD Cowen担任此次交易的联合账簿管理人。","market":"sh","thumbnail":"https://static.tigerbbs.com/8d7665b640c6daf26b451cc5367e24e1","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/8d7665b640c6daf26b451cc5367e24e1"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1390920.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["AKTS","BK1147","BK4007","BK4148"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2601988176","title":"抗癌生物科技公司Aktis Oncology(AKTS.US)IPO定价16-18美元/股 拟筹资2.12亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2601988176","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601988176?lang=zh_cn&edition=full","pubTime":"2026-01-05 21:16","pubTimestamp":1767619009,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，专注于放射性药物疗法研发的临床阶段生物科技公司Aktis Oncology Inc.计划在美国进行首次公开募股，筹资至多2.12亿美元。此次拟议上市正值2026年初可能迎来一波密集IPO之际。目前，Aktis已从包括MPM、Vida、EcoR1 Capital和Blue Owl Capital在内的顶尖生命科学机构投资者财团筹集了约3.46亿美元。招股文件还披露，IPO前，MPM关联公司持有Aktis 26%的股份，Vida Ventures持有14%，EcoR1持有11%，Blue Owl持有7%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1388886.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159837","AKTS","BK4148"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2593071851","title":"1期实体瘤生物技术公司Aktis Oncology(AKTS.US)申请美股IPO 拟筹资1亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2593071851","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593071851?lang=zh_cn&edition=full","pubTime":"2025-12-22 16:05","pubTimestamp":1766390712,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，专注于研发实体瘤靶向放射性药物的临床Ⅰ期生物科技企业Aktis Oncology于上周五向美国证券交易委员会提交申请，拟通过首次公开募股募资至多1亿美元。据介绍，Aktis Oncology是一家临床阶段肿瘤药企，核心研发方向为用于治疗高发实体瘤的α粒子发射型放射性药物。公司计划在纳斯达克挂牌上市，股票代码为AKTS。本次IPO的联席账簿管理人包括摩根大通、美银证券、Leerink Partners以及TD Cowen，具体发行定价条款尚未对外披露。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1384365.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4148","AKTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2492692059","title":"Akoustis Technologies, Inc.盘中异动 早盘快速下挫5.87%报0.039美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492692059","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492692059?lang=zh_cn&edition=full","pubTime":"2024-12-17 22:33","pubTimestamp":1734446011,"startTime":"0","endTime":"0","summary":"北京时间2024年12月17日22时33分，Akoustis Technologies, Inc.股票出现异动，股价大幅下挫5.87%。Akoustis Technologies, Inc.股票所在的通讯公司行业中，整体跌幅为0.76%。其相关个股中，创力、UT斯达康、Mynaric Ag涨幅较大，Amplitech Group, Inc.、Ondas Holdings Inc.、Siyata Mobile, Inc.较为活跃，换手率分别为8.26%、7.09%、6.63%，振幅较大的相关个股有Akoustis Technologies, Inc.、Ondas Holdings Inc.、康姆泰克通讯，振幅分别为9.54%、9.34%、7.58%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217223331984c9025&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217223331984c9025&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AKTS","BK4148"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2491690559","title":"Akoustis Technologies, Inc.股价重挫31.67% 市值跌225.9万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491690559","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491690559?lang=zh_cn&edition=full","pubTime":"2024-12-16 22:34","pubTimestamp":1734359646,"startTime":"0","endTime":"0","summary":"北京时间2024年12月16日22时34分，Akoustis Technologies, Inc.股票出现异动，股价急速下挫31.67%。Akoustis Technologies, Inc.股票所在的通讯公司行业中，整体跌幅为0.33%。其相关个股中，Ondas Holdings Inc.、Mobilicom Ltd、Amplitech Group Inc. C/Wts 26/02/2026涨幅较大，Amplitech Group, Inc.、Akoustis Technologies, Inc.、Ondas Holdings Inc.较为活跃，换手率分别为21.75%、7.75%、4.29%，振幅较大的相关个股有Amplitech Group, Inc.、Ondas Holdings Inc.、Mobilicom Ltd，振幅分别为17.75%、12.86%、6.12%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216223406a1f34401&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216223406a1f34401&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AKTS","BK4148"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2491788375","title":"Akoustis Technologies, Inc.盘中异动 股价大跌5.77%报0.072美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491788375","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491788375?lang=zh_cn&edition=full","pubTime":"2024-12-13 22:35","pubTimestamp":1734100527,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日22时35分，Akoustis Technologies, Inc.股票出现异动，股价大幅跳水5.77%。Akoustis Technologies, Inc.股票所在的通讯公司行业中，整体涨幅为0.19%。Akoustis Technologies, Inc.公司简介：Akoustis Technologies Inc 是一家新兴的商业产品公司，专注于为无线行业开发、设计和制造创新的射频滤波器解决方案，包括智能手机和平板电脑、网络基础设施设备、WiFi 客户端设备和国防应用等产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121322352795e976df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121322352795e976df&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4148","AKTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2490863363","title":"Akoustis Technologies, Inc.盘中异动 早盘股价大跌5.09%报0.080美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490863363","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490863363?lang=zh_cn&edition=full","pubTime":"2024-12-11 22:32","pubTimestamp":1733927559,"startTime":"0","endTime":"0","summary":"北京时间2024年12月11日22时32分，Akoustis Technologies, Inc.股票出现异动，股价快速下挫5.09%。截至发稿，该股报0.080美元/股，成交量104.534万股，换手率0.68%，振幅5.33%。Akoustis Technologies, Inc.股票所在的通讯公司行业中，整体涨幅为0.36%。Akoustis Technologies, Inc.公司简介：Akoustis Technologies Inc 是一家新兴的商业产品公司，专注于为无线行业开发、设计和制造创新的射频滤波器解决方案，包括智能手机和平板电脑、网络基础设施设备、WiFi 客户端设备和国防应用等产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211223240a1e66b58&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211223240a1e66b58&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AKTS","BK4148"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2490215773","title":"Akoustis Technologies, Inc.盘中异动 早盘快速下挫5.90%报0.091美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490215773","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490215773?lang=zh_cn&edition=full","pubTime":"2024-12-09 22:32","pubTimestamp":1733754738,"startTime":"0","endTime":"0","summary":"北京时间2024年12月09日22时32分，Akoustis Technologies, Inc.股票出现波动，股价大幅下挫5.90%。Akoustis Technologies, Inc.股票所在的通讯公司行业中，整体跌幅为0.16%。Akoustis Technologies, Inc.公司简介：Akoustis Technologies Inc 是一家新兴的商业产品公司，专注于为无线行业开发、设计和制造创新的射频滤波器解决方案，包括智能手机和平板电脑、网络基础设施设备、WiFi 客户端设备和国防应用等产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209223219ab6a0a19&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209223219ab6a0a19&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4148","AKTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2489341752","title":"Akoustis Technologies, Inc.盘中异动 早盘股价大涨5.16%报0.100美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489341752","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489341752?lang=zh_cn&edition=full","pubTime":"2024-12-06 23:12","pubTimestamp":1733497955,"startTime":"0","endTime":"0","summary":"北京时间2024年12月06日23时12分，Akoustis Technologies, Inc.股票出现波动，股价急速拉升5.16%。截至发稿，该股报0.100美元/股，成交量114.124万股，换手率0.74%，振幅6.00%。Akoustis Technologies, Inc.股票所在的通讯公司行业中，整体跌幅为0.08%。Akoustis Technologies, Inc.公司简介：Akoustis Technologies Inc 是一家新兴的商业产品公司，专注于为无线行业开发、设计和制造创新的射频滤波器解决方案，包括智能手机和平板电脑、网络基础设施设备、WiFi 客户端设备和国防应用等产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206231235a1d985a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206231235a1d985a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AKTS","BK4148"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2489468888","title":"Akoustis Technologies, Inc.盘中异动 急速跳水5.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489468888","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489468888?lang=zh_cn&edition=full","pubTime":"2024-12-05 22:32","pubTimestamp":1733409155,"startTime":"0","endTime":"0","summary":"北京时间2024年12月05日22时32分，Akoustis Technologies, Inc.股票出现异动，股价急速下挫5.53%。Akoustis Technologies, Inc.股票所在的通讯公司行业中，整体涨幅为0.01%。其相关个股中，Boxlight Corporation、慧与、Silynxcom Ltd.涨幅较大，Mobilicom Ltd、Akoustis Technologies, Inc.、Siyata Mobile, Inc.较为活跃，换手率分别为0.39%、0.34%、0.30%，振幅较大的相关个股有Akoustis Technologies, Inc.、Boxlight Corporation、Cambium Networks Corporation，振幅分别为10.04%、7.41%、6.72%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205223235971be146&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205223235971be146&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AKTS","BK4148"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2488883190","title":"Akoustis Technologies, Inc.盘中异动 大幅拉升7.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488883190","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488883190?lang=zh_cn&edition=full","pubTime":"2024-12-04 22:31","pubTimestamp":1733322670,"startTime":"0","endTime":"0","summary":"北京时间2024年12月04日22时31分，Akoustis Technologies, Inc.股票出现异动，股价快速上涨7.41%。Akoustis Technologies, Inc.股票所在的通讯公司行业中，整体涨幅为0.19%。其相关个股中，UT斯达康、Akoustis Technologies, Inc.、吉来特卫星网络涨幅较大，应用光电、Mobilicom Ltd、Siyata Mobile, Inc.较为活跃，换手率分别为0.63%、0.44%、0.43%，振幅较大的相关个股有Ceragon网络、Siyata Mobile, Inc.、应用光电，振幅分别为3.51%、3.41%、2.49%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204223110abf5c813&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204223110abf5c813&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AKTS","BK4148"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2488729696","title":"Akoustis Technologies, Inc.盘中异动 急速上涨7.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488729696","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488729696?lang=zh_cn&edition=full","pubTime":"2024-12-02 22:33","pubTimestamp":1733150009,"startTime":"0","endTime":"0","summary":"北京时间2024年12月02日22时33分，Akoustis Technologies, Inc.股票出现波动，股价大幅拉升7.52%。Akoustis Technologies, Inc.股票所在的通讯公司行业中，整体跌幅为0.28%。其相关个股中，Mobilicom Ltd、Ondas Holdings Inc.、Silynxcom Ltd.涨幅较大，Mobilicom Ltd、Ondas Holdings Inc.、Akoustis Technologies, Inc.较为活跃，换手率分别为29.92%、7.04%、1.10%，振幅较大的相关个股有Mobilicom Ltd、Ondas Holdings Inc.、Vislink技术，振幅分别为19.34%、15.24%、7.52%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202223329971b2e12&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202223329971b2e12&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4148","AKTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2487856583","title":"Akoustis Technologies, Inc.盘中异动 早盘股价大跌5.45%报0.104美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2487856583","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2487856583?lang=zh_cn&edition=full","pubTime":"2024-11-29 22:52","pubTimestamp":1732891975,"startTime":"0","endTime":"0","summary":"北京时间2024年11月29日22时52分，Akoustis Technologies, Inc.股票出现波动，股价大幅下跌5.45%。Akoustis Technologies, Inc.股票所在的通讯公司行业中，整体涨幅为0.28%。其相关个股中，Ondas Holdings Inc.、应用光电、Silynxcom Ltd.涨幅较大，Ondas Holdings Inc.、应用光电、Siyata Mobile, Inc.较为活跃，换手率分别为10.32%、2.45%、2.27%，振幅较大的相关个股有Ondas Holdings Inc.、应用光电、Akoustis Technologies, Inc.，振幅分别为23.08%、10.02%、9.09%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241129225255abe8f0c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241129225255abe8f0c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4148","AKTS"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.aktisoncology.com","stockEarnings":[{"period":"1week","weight":-0.0902},{"period":"1month","weight":-0.0579},{"period":"3month","weight":0.0032},{"period":"6month","weight":0.0483},{"period":"ytd","weight":0.0483}],"compareEarnings":[{"period":"1week","weight":-0.025},{"period":"1month","weight":0.0051},{"period":"3month","weight":0.0969},{"period":"6month","weight":0.0756},{"period":"1year","weight":0.2437},{"period":"ytd","weight":0.0816}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Aktis Oncology, Inc.于2020年8月根据特拉华州法律成立。该公司是一家临床阶段的肿瘤学公司，利用其专有的小蛋白平台开发靶向放射性药物。其主要候选药物[225Ac]Ac-AKY-1189靶向Nectin-4，目前正处于针对尿路上皮癌及其他表达Nectin-4的实体瘤的1b期临床开发阶段。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":0.07242},{"month":2,"riseRate":0.428571,"avgChangeRate":-0.009578},{"month":3,"riseRate":0.285714,"avgChangeRate":-0.089105},{"month":4,"riseRate":0.25,"avgChangeRate":-0.011983},{"month":5,"riseRate":0.5,"avgChangeRate":-0.07198},{"month":6,"riseRate":0.5,"avgChangeRate":-0.041124},{"month":7,"riseRate":0.25,"avgChangeRate":-0.065017},{"month":8,"riseRate":0.5,"avgChangeRate":-0.046698},{"month":9,"riseRate":0.375,"avgChangeRate":-0.092023},{"month":10,"riseRate":0.375,"avgChangeRate":-0.160528},{"month":11,"riseRate":0.625,"avgChangeRate":0.149228},{"month":12,"riseRate":0.375,"avgChangeRate":0.01269}],"exchange":"NASDAQ","name":"Aktis Oncology","nameEN":"Aktis Oncology"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Aktis Oncology(AKTS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Aktis Oncology(AKTS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Aktis Oncology,AKTS,Aktis Oncology股票,Aktis Oncology股票老虎,Aktis Oncology股票老虎国际,Aktis Oncology行情,Aktis Oncology股票行情,Aktis Oncology股价,Aktis Oncology股市,Aktis Oncology股票价格,Aktis Oncology股票交易,Aktis Oncology股票购买,Aktis Oncology股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Aktis Oncology(AKTS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Aktis Oncology(AKTS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}